Concomitant myelosuppressive chemotherapy

Also known as: Anemia post chemotherapy / Anaemia post chemotherapy / Anemia / Anaemia, unspecified / Unspecified anaemia / Unspecified anemia / Anemia, unspecified / Anaemia / Anaemia NOS

Drugs
Drugs and Targets

Drug	Drug Name	Drug Description
DB18704	Efbemalenograstim alfa	A granulocyte-colony stimulating factor used to treat prevent chemotherapy-induced neutropenia.
DB00016	Erythropoietin	A recombinant form of human erythropoietin used to increase differentiation of progenitor cells to red blood cells in the treatment of anemia.
DB01592	Iron	An essential element commonly used for the treatment of patients with documented iron deficiency.
DB00019	Pegfilgrastim	A recombinant human granulocyte colony stimulating factor used to stimulate the production of neutrophils and prevent febrile neutropenia or infections after myelosuppressive chemotherapy.

Drug	Drug Name	Target	Type
DB18704	Efbemalenograstim alfa	Granulocyte colony-stimulating factor receptor	target
DB00016	Erythropoietin	Erythropoietin receptor	target
DB01592	Iron	Transferrin receptor protein 1	target
DB01592	Iron	Egl nine homolog 1	target
DB01592	Iron	Histone deacetylase 8	target
DB01592	Iron	Alpha-hemoglobin-stabilizing protein	target
DB01592	Iron	Hemoglobin subunit alpha	target
DB01592	Iron	Frataxin, mitochondrial	target
DB01592	Iron	Ferritin heavy chain	target
DB01592	Iron	Flap endonuclease 1	target
DB01592	Iron	Endonuclease 8-like 1	target
DB01592	Iron	Endonuclease 8-like 2	target
DB01592	Iron	DNA polymerase beta	target
DB01592	Iron	Ceruloplasmin	target
DB01592	Iron	Serotransferrin	target
DB00019	Pegfilgrastim	Granulocyte colony-stimulating factor receptor	target
DB00019	Pegfilgrastim	Neutrophil elastase	enzyme

Drug	Drug Name	Phase	Status	Count